The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins

AAPS PharmSciTech

Volumn 6, Issue 2, 2005, Pages

  Panigrahi, Lalatendu ^a   Pattnaik, Snigdha ^b,d   Ghosal, Saroj K ^c  

^a Sun Pharma Advanced Research Centre   (India)

^b SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

^c JADAVPUR UNIVERSITY   (India)

^d NONE   (India)

Author keywords

Enhancer; Human cadaver skin; Isopropyl myristate; Permeation; Terbutaline sulfate

Indexed keywords

BUFFER; ESTER; ESTER DERIVATIVE; LANOLIC ACID ISOPROPYL ESTER; LAURIC ACID DERIVATIVE; LAURIC ACID METHYL ESTER; MYRISTIC ACID ISOPROPYL ESTER; OCTANOL; SKIN LIPID; TERBUTALINE SULFATE; UNCLASSIFIED DRUG;

ABDOMEN; ADULT; ANIMAL TISSUE; ARTICLE; CADAVER; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIFFUSION COEFFICIENT; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; EPIDERMIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MATHEMATICAL COMPUTING; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PH MEASUREMENT; SKIN IRRITATION; SKIN PENETRATION; SKIN PERMEABILITY; SKINFOLD THICKNESS; SPECIES DIFFERENCE; STEADY STATE;

ADMINISTRATION, CUTANEOUS; ADULT; ANIMALS; CADAVER; DRUG DELIVERY SYSTEMS; ESTERS; HUMANS; HYDROGEN-ION CONCENTRATION; LATEX; MALE; MICE; ORGANIC CHEMICALS; SKIN ABSORPTION; TERBUTALINE;

EID: 27744519546     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt060225     Document Type: Article

References (25)

1. 2-sympathomimetic, in healthy volunteers and asthmatic patients. Arzneimittelforschung. 1982;32:159-164.
2. 49 lymphoma cells. A mechanism of desensitization. J Biol Chem. 1983;258:13597-13605.
3. Thassu D, Vyas SP. Controlled transdermal mucolytic delivery system. Drug Dev Ind Pharm. 1991;17:561-576.
4. Shaw JE, Cramer HP, Gale R. Rate-controlled transdermal therapy utilizing polymeric membranes. In: Kydonious AF, Berner B, eds. Transdermal Delivery of Drugs. Boca Raton, FL: CRC Press; 1987;102-116.
5. Chang RK, Price JC. Preparation and preliminary evaluation of Eudragit RL and RS pseudolatices for controlled drug release. Drug Dev Ind Pharm. 1989;15:361-372.
6. Ahuja AS, Ashman J. Terbutaline sulphate. In: Florey K, ed. Analytical Profile of Drug Substance. New York, NY: Academic press; 1990:603-625.
7. Leo A, Hansch C, Elkins D. Partition coefficients and their uses. Chem Rev. 1971;71:525-616.
8. Chiang CH, Lai JS, Yang KH. The effect of pH and chemical enhancers on the percutaneous absorption of indomethacin. Drug Dev Ind Pharm. 1991;17:91-111.
9. Valia KH, Tajo K, Chien YW. Long term permeation kinetics of estradiol. Part-3, kinetic analysis of the simultaneous skin permeation and bioconversion of estradiol esters. Drug Dev Ind Pharm. 1985;11:1133-1173.
10. Tojo K, Chiang CC, Chien YW. Drug permeation across the skin: effect of penetrant hydrophilicity. J Pharm Sci. 1987;76:123-126.
11. Guy RH, Hadgrft J. Pharmacokinetic interpretation of plasma levels of clonidine following transdermal delivery. J Pharm Sci. 1985;74:1016-1018.
12. Bhattacharya A, Ghosal SK. Permeation kinetics of ketotifen fumarate along and in combination with hydrophobic permeation enhancers through human cadaver epidermis. Boll Chim Farm. 2000;139:177-181.
13. Murty SN, Hiremath SRR. Physical and chemical enhancers in transdermal delivery of terbutaline sulphate. AAPS PharmSciTech. 2001;2:1-5.
14. Durrhim H, Flynn GL, Higuchi WI, Behl CR. Permeation of hairless mouse skin I: experimental method and comparison with human epidermal permeation by alkanol. J Pharm Sci. 1980;69:781-786.
15. Raykar PV, Fung MC, Anderson BD. The role of protein and lipid domains in the uptake of solutes by human stratum corneum. Pharm Res. 1998;5:140-150.
16. Kakkar AP, Gupta A. Gelatin based transdermal therapeutic system. Indian Drugs. 1992;29:308-312.
17. Panigrahi L, Ghosal SK. Formulation and evaluation of pseudolatex transdermal drug delivery system of terbutaline sulphate. Ind J Pharm Sci. 2002;1:79-82.
18. Das Gupta V, Parasrampuria J, Gardner SN. Chemical stability of isoetharine hydrochloride, metaproterenol sulphate and terbutaline sulphate after mixing with normal saline for respiratory therapy. J Clin Pharm Ther. 1988;13:165-169.
19. Shah JC. Analysis of permeation data: evaluation of the lag time method. Int J Pharm. 1993;90:161-169.
20. Saket MM, James KC, Kellaway IW. Partitioning of some 21 alkyl esters of hydrocortisone and cortisone. Int J Pharm. 1984;21:155-166.
21. Aslani P, Kennedy RA. Studies on diffusion in alginate gels I. Effect of cross-linking with calcium or zinc ions on diffusion of acetaminophen. J Control Release. 1996;42:75-82.
22. Pefile SC, Smith EW, Albrecht CF, Kruger PB. Release of rooperol tetra-acetate from topical bases: in vitro studies using silicone membrane. J Control Release. 1998;161:237-243.
23. Yu JW, Chien T, Chien YW. Transdermal dual controlled delivery of testosterone and estradiol. I. Impact of system design. Drug Dev Ind Pharm. 1991;17:1883-1904.
24. Scheuplein R, Ross L. Effect of surfactants and solvents on the permeability of epidermis. J Soc Cosmet Chem. 1970;22:853-873.
25. Mandal SC, Bhattacharyya M, Ghosal SK. In vitro release and permeation kinetic of pentazocine from matrix-dispersion type transdermal drug delivery system. Drug Dev Ind Pharm. 1994;20:1933-1941.